These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12839930)

  • 1. Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.
    Willhauck M; Scheibenbogen C; Pawlita M; Möhler T; Thiel E; Keilholz U
    Cancer Res; 2003 Jul; 63(13):3483-5. PubMed ID: 12839930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy.
    Willhauck M; Möhler T; Scheibenbogen C; Pawlita M; Brossart P; Schmier JW; Keilholz U
    Clin Cancer Res; 1996 Apr; 2(4):767-72. PubMed ID: 9816229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
    Zhu X; Zhu P; Guo XL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ cytokine therapy: redistribution of clonally expanded T cells.
    thor Straten P; Guldberg P; Schrama D; Andersen MH; Moerch U; Seremet T; Siedel C; Reisfeld RA; Becker JC
    Eur J Immunol; 2001 Jan; 31(1):250-8. PubMed ID: 11265641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
    Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
    Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: T-cell receptor expression in distinct brain regions.
    Junker A; Ivanidze J; Malotka J; Eiglmeier I; Lassmann H; Wekerle H; Meinl E; Hohlfeld R; Dornmair K
    Brain; 2007 Nov; 130(Pt 11):2789-99. PubMed ID: 17890278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
    Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the CDR3 region of alpha/beta T-cell receptors (TCRs) and TCR BD gene double-stranded recombination signal sequence breaks end in peripheral blood mononuclear cells of T-lineage acute lymphoblastic leukemia.
    Xin-Sheng Y; Zheng-Jun X; Li M; Wan-Bang S; Wei-Yang Z; Qian W; Zhi-Ming H; Min-Jie M; Ying L; Zhen-Qiang W; Xiao-Wei H; Ju-Fang W; Xiao-Ning W
    Clin Lab Haematol; 2006 Dec; 28(6):405-15. PubMed ID: 17105495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identical T-cell receptor transcripts in multiple melanoma metastases.
    Schrama D; Fuchs E; Bröcker EB; Thor Straten P; Becker JC
    Cancer Res; 2002 Oct; 62(20):5664-7. PubMed ID: 12384521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
    Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
    Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.
    Card KF; Price-Schiavi SA; Liu B; Thomson E; Nieves E; Belmont H; Builes J; Jiao JA; Hernandez J; Weidanz J; Sherman L; Francis JL; Amirkhosravi A; Wong HC
    Cancer Immunol Immunother; 2004 Apr; 53(4):345-57. PubMed ID: 14610621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.
    Godefroy E; Wang Y; Souleimanian NE; Scotto L; Stevanovic S; Chen YT; Valmori D; Ayyoub M
    Cancer Immunol Immunother; 2007 Aug; 56(8):1183-92. PubMed ID: 17186289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.
    Straten Pt; Dahl C; Schrama D; Pedersen LØ; Andersen MH; Seremet T; Bröcker EB; Guldberg P; Becker JC
    Cancer Immunol Immunother; 2006 May; 55(5):495-502. PubMed ID: 16001163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.
    Ebert LM; Liu YC; Clements CS; Robson NC; Jackson HM; Markby JL; Dimopoulos N; Tan BS; Luescher IF; Davis ID; Rossjohn J; Cebon J; Purcell AW; Chen W
    Cancer Res; 2009 Feb; 69(3):1046-54. PubMed ID: 19176376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites.
    Strohal R; Brna C; Mossbacher U; Fischer G; Pehamberger H; Stingl G
    J Invest Dermatol; 1998 Dec; 111(6):1085-91. PubMed ID: 9856821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues.
    Derré L; Bruyninx M; Baumgaertner P; Ferber M; Schmid D; Leimgruber A; Zoete V; Romero P; Michielin O; Speiser DE; Rufer N
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15010-5. PubMed ID: 18809922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.